Roivant Historical Cash Flow
| ROIV Stock | USD 12.46 0.07 0.56% |
Analysis of Roivant Sciences cash flow over time is an excellent tool to project Roivant Sciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Stock Based Compensation of 228.9 M or Change In Working Capital of 23.7 M as it is a great indicator of Roivant Sciences ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Roivant Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Roivant Sciences is a good buy for the upcoming year.
Roivant |
About Roivant Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Roivant balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Roivant's non-liquid assets can be easily converted into cash.
Roivant Sciences Cash Flow Chart
Add Fundamental
Investments
Securities or assets acquired for generating income or appreciating in value, not used in daily operations.Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Capital Expenditures
Capital Expenditures are funds used by Roivant Sciences to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Roivant Sciences operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Roivant Sciences' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Roivant Sciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Roivant Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide.At this time, Roivant Sciences' Sale Purchase Of Stock is fairly stable compared to the past year. Investments is likely to climb to about 5.5 B in 2024, whereas Free Cash Flow is likely to drop (805 M) in 2024.
| 2022 | 2023 | 2024 (projected) | Stock Based Compensation | 217.8M | 199.6M | 228.9M | Net Borrowings | 129.8M | 116.8M | 61.9M |
Roivant Sciences cash flow statement Correlations
Click cells to compare fundamentals
Roivant Sciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Roivant Sciences cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 1.3B | (127.6M) | (67.6M) | (381.9M) | 4.9B | 5.1B | |
| Stock Based Compensation | 122.6M | 85.0M | 565.0M | 217.8M | 199.6M | 228.9M | |
| Free Cash Flow | (766.7M) | (557.9M) | (695.2M) | (856.1M) | (766.7M) | (805.0M) | |
| Change In Working Capital | 15.3M | 71.9M | 15.7M | 6.3M | 19.0M | 23.7M | |
| Begin Period Cash Flow | 849.6M | 2.3B | 2.1B | 2.1B | 1.7B | 1.6B | |
| Total Cashflows From Investing Activities | 1.7B | (31.7M) | 303.3M | (44.3M) | (39.8M) | (37.8M) | |
| Other Cashflows From Financing Activities | 83.5M | 508K | 292.0M | 312.3M | 11.5M | 10.9M | |
| Other Non Cash Items | (264.3M) | 191.2M | (340.2M) | 33.4M | (5.2B) | (5.0B) | |
| Capital Expenditures | 4.9M | 5.8M | 17.4M | 12.7M | 1.4M | 1.3M | |
| Total Cash From Operating Activities | (761.8M) | (552.1M) | (677.7M) | (843.4M) | (765.3M) | (803.5M) | |
| Change To Operating Activities | 6.4M | 103.7M | (6.3M) | 2.0M | 1.8M | 1.7M | |
| Net Income | (519.4M) | (900.2M) | (924.1M) | (1.1B) | 4.2B | 4.4B | |
| Total Cash From Financing Activities | 217.2M | 456.3M | 306.8M | 499.5M | 419.4M | 355.5M | |
| End Period Cash Flow | 2.2B | 2.1B | 2.1B | 1.7B | 6.6B | 6.9B | |
| Change To Netincome | (2.0B) | 147.3M | 222.3M | 275.9M | 317.2M | 333.1M | |
| Change To Liabilities | 6.6M | 6.0M | 84.0M | 43.3M | 49.8M | 31.8M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Roivant Stock Analysis
When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.